After a cardiovascular event, it proves difficult to maintain a healthier, more active lifestyle over the long term. Although sedentary time decreases after participation in a cardiac rehabilitation lifestyle program, it ...
Mar 25, 2025
0
0
For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with lower bleeding risk, without ...
Feb 19, 2025
0
0
A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth of plaque in the coronary arteries and an increased risk of cardiovascular events. The results ...
Feb 4, 2025
0
1
A new study uncovers how the COVID-19 pandemic reshaped emergency care for acute coronary syndrome, with a sharp decline in hospital visits nationwide. Analyzing over 61,000 cases, the research reveals that older adults, ...
Dec 19, 2024
0
0
An investigation published in The BMJ raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the US and Brilique in Europe), ...
Dec 12, 2024
0
26
A new, rapid blood test that spots whether people are having a heart attack could improve the treatment of people presenting with chest pain at emergency departments, according to late-breaking research presented in a Hot ...
Sep 3, 2024
0
1
Telemedicine support to village doctors could hold the key to improving access to care for China's rural elderly at risk for developing potentially life-threatening complications resulting from untreated atrial fibrillation ...
Sep 2, 2024
0
0
Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as long-term antithrombotic therapy, in patients with high-risk atrial fibrillation (AF) and stable ...
Sep 2, 2024
0
0
New research presented at this year's ESC Congress 2024 in London, UK (30 Aug–2 Sept) shows that among patients admitted to the intensive cardiac care unit (ICCU), those with a recent history of recreational drug use are ...
Aug 28, 2024
0
0
How a person's immune system responds to a protein called LL-37 may increase the risk of developing acute coronary syndrome, but the response may also serve as a potential target for future treatments. These findings come ...
Jul 25, 2024
0
3
Acute coronary syndrome (ACS) is usually one of three diseases involving the coronary arteries: ST elevation myocardial infarction (30%), non ST elevation myocardial infarction (25%), or unstable angina (38%).
These types are named according to the appearance of the electrocardiogram (ECG/EKG) as non-ST segment elevation myocardial infarction (NSTEMI) and ST segment elevation myocardial infarction (STEMI). There can be some variation as to which forms of MI are classified under acute coronary syndrome.
ACS should be distinguished from stable angina, which develops during exertion and resolves at rest. In contrast with stable angina, unstable angina occurs suddenly, often at rest or with minimal exertion, or at lesser degrees of exertion than the individual's previous angina ("crescendo angina"). New onset angina is also considered unstable angina, since it suggests a new problem in a coronary artery.
Though ACS is usually associated with coronary thrombosis, it can also be associated with cocaine use. Cardiac chest pain can also be precipitated by anemia, bradycardias (excessively slow heart rate) or tachycardias (excessively fast heart rate).
This text uses material from Wikipedia licensed under CC BY-SA
